Full history for every metric is available with a Kvantra account
Trimurthi Limited (TRIMURTHI.BO)
Key financial summary
Financials in INR| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | INR m | 92 | 8 | 14 | 42 | 307 | 1,323 | 1,469 |
| Operating profit | INR m | 47 | 62 | |||||
| Net profit | INR m | -38 | -16 | -1 | 0 | 1 | 26 | 36 |
| EPS reported | INR | 1.21 | 1.76 | |||||
| Operating cashflow per share | INR | -10.62 | 0.00 | |||||
| Capex per share | INR | 1.54 | 0.00 | |||||
| FCF per share | INR | -12.16 | 0.00 | |||||
| Free cash flow | INR m | -256 | 0 | |||||
| Net debt | INR m | -30 | -30 | |||||
| Book value equity | INR m | 465 | 465 | |||||
| Book value per share | INR | 22.05 | 19.32 | |||||
| Number of shares | m | 21.09 | 24.06 | |||||
| DPS (TTM paid) | INR | 0.00 | 0.00 |
Financial summary
Financials in INR| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 21.99 | 15.12 | |||||
| P/B LTM | x | 1.21 | 0.57 | |||||
| P/S LTM | x | 0.42 | 0.18 | |||||
| P/FCF LTM | x | -2.19 | 0.00 | |||||
| EV/EBITDA LTM | x | 15.06 | 5.15 | |||||
| EV/Sales LTM | x | 0.40 | 0.16 | |||||
| Earnings Yield LTM | % | 4.55% | 6.61% | |||||
| FCF Yield | % | -45.71% | 0.00% | |||||
| Quality | ||||||||
| ROE | % | 5.50% | 10.07% | |||||
| ROIC | % | 7.63% | 0.00% | |||||
| Operating margin | % | 3.57% | 4.20% | |||||
| Gross margin | % | 4.14% | 4.74% | |||||
| FCF/Sales | % | -19.38% | 0.00% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +1323.5% | - | |||||
| Sales Growth YoY | % | +330.59% | +179.99% | |||||
| Net Income Growth YoY | % | +2925.6% | +565.25% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | +332.71% | +217.57% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | -0.84 | 0.00 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -5.27% | -11.17% | |||||
| Net debt/Equity | x | -0.06 | -0.06 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Trimurthi Limited functions as a parent company primarily engaged in the pharmaceutical sector, encompassing the distribution, retail, and promotion of various medical products. Its business operations are structured across several divisions, including its core pharmaceutical ventures, financial services, investment activities, and equity trading. The company's product portfolio features medicines for family planning, women's health (obstetrics and gynecology), gastrointestinal conditions, and other therapeutic areas. Established on December 13, 1994, its corporate headquarters are situated in Hyderabad, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Trimurthi Limited (TRIMURTHI.BO)
Trimurthi Limited functions as a parent company primarily engaged in the pharmaceutical sector, encompassing the distribution, retail, and promotion of various medical products. Its business operations are structured across several divisions, including its core pharmaceutical ventures, financial services, investment activities, and equity trading. The company's product portfolio features medicines for family planning, women's health (obstetrics and gynecology), gastrointestinal conditions, and other therapeutic areas. Established on December 13, 1994, its corporate headquarters are situated in Hyderabad, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free